Mañé JM - Search Results

1

A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer.

López-Vivanco G, Fuente N, Barceló R, Rubio I, Muñoz A, Mañé JM, Pérez-Hoyos T, Viteri A, Ferreiro J. López-Vivanco G, et al. Among authors: mane jm. Int J Clin Pharmacol Res. 2003;23(1):9-16. Int J Clin Pharmacol Res. 2003. PMID: 14621068

2

Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma.

Mané JM, Sancho A, Muñoz A, Rubio I, Fernández R, Carrera S, Fuente N, Ballesteros D, Casas R, Marrodán I, Mielgo X, López-Vivanco G. Mané JM, et al. Tumori. 2010 May-Jun;96(3):405-10. doi: 10.1177/030089161009600305. Tumori. 2010. PMID: 20845800 Clinical Trial.

3

Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases.

Barceló R, López-Vivanco G, Mañé JM, Rubio I, Muñoz A, Fernández R. Barceló R, et al. Among authors: mane jm. Ann Oncol. 2000 Sep;11(9):1191-4. doi: 10.1023/a:1008368019203. Ann Oncol. 2000. PMID: 11061617 Free article. No abstract available.

4

Amyloidosis and lung cancer.

Barceló JR, Muñoz A, Mañé JM, Rubio I, Pérez-Hoyos T, Viteri A, López-Vivanco GM. Barceló JR, et al. Among authors: mane jm. Clin Lung Cancer. 2003 Jan;4(4):249-51; discussion 252. doi: 10.3816/clc.2003.n.006. Clin Lung Cancer. 2003. PMID: 14624716

5

Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme.

Mañé JM, Fernández R, Muñoz A, Rubio I, Ferreiro J, López-Argumedo G, Barceló R, López-Vivanco G. Mañé JM, et al. Tumori. 2004 Nov-Dec;90(6):562-6. doi: 10.1177/030089160409000605. Tumori. 2004. PMID: 15762357 Clinical Trial.

6

[Addisonian crisis as first manifestation of adrenal gland insufficiency in patient diagnosed with lung cancer].

Muñoz A, Oñate J, Mañé JM, Rubio I, Fernández R, Barceló JR, López Vivanco G. Muñoz A, et al. Among authors: mane jm. An Med Interna. 2001 Jan;18(1):35-7. An Med Interna. 2001. PMID: 11387844 Spanish.

7

Gemcitabine and vascular toxicity.

Muñoz A, Mañé JM, Rubio I, Fernández R, Fuente N, Barceló R, López Vivanco G. Muñoz A, et al. Among authors: mane jm. Lung Cancer. 2002 Aug;37(2):229. doi: 10.1016/s0169-5002(02)00152-6. Lung Cancer. 2002. PMID: 12140148 No abstract available.

8

Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer.

Muñoz A, Barceló R, Rubio I, Mañé JM, Ferreiro J, López-Vivanco G. Muñoz A, et al. Among authors: mane jm. J Natl Cancer Inst. 2003 Aug 20;95(16):1252-3. doi: 10.1093/jnci/djg034. J Natl Cancer Inst. 2003. PMID: 12928355 No abstract available.

9

Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer.

Muñoz A, Carrera S, Ferreiro J, de Lobera AR, Mañé JM, López-Vivanco G. Muñoz A, et al. Among authors: mane jm. Ann Oncol. 2007 Dec;18(12):2045-6. doi: 10.1093/annonc/mdm515. Ann Oncol. 2007. PMID: 18083694 Free article. No abstract available.

10

Tumor lysis syndrome in a multiple myeloma treated with thalidomide.

Fuente N, Mañe JM, Barcelo R, Muñoz A, Perez-Hoyos T, Lopez-Vivanco G. Fuente N, et al. Among authors: mane jm. Ann Oncol. 2004 Mar;15(3):537. doi: 10.1093/annonc/mdh116. Ann Oncol. 2004. PMID: 14998862 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page